BB
BB Biotech Portfolio holdings
AUM
$3.98B
This Quarter Return
+13.76%
1 Year Return
+15.06%
3 Year Return
+120.36%
5 Year Return
+263.74%
10 Year Return
–
AUM
$3.69B
AUM Growth
+$3.69B
(+9.9%)
Cap. Flow
+$61.5M
Cap. Flow
% of AUM
1.67%
Top 10 Holdings %
Top 10 Hldgs %
69.25%
Holding
31
New
4
Increased
15
Reduced
5
Closed
2
Top Buys
| 1 |
ALDR
Alder Biopharmaceuticals, Inc.
ALDR
|
$61.2M |
| 2 |
JUNO
Juno Therapeutics, Inc.
JUNO
|
$24M |
| 3 |
KITE
Kite Pharma, Inc.
KITE
|
$21.3M |
| 4 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$19M |
| 5 |
CEMP
Cempra, Inc.
CEMP
|
$18.7M |
Top Sells
| 1 |
GEVA
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
|
$100M |
| 2 |
IMGN
Immunogen Inc
IMGN
|
$25.4M |
| 3 |
Gilead Sciences
GILD
|
$17.6M |
| 4 |
Innoviva
INVA
|
$9.04M |
| 5 |
Halozyme
HALO
|
$7.82M |
Sector Composition
| 1 | Healthcare | 82.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
KITE
26
DELISTED
Kite Pharma, Inc.
KITE
| $21.3M | 0.58% |
+350,000
| New | +$21.3M |
|
|
ACHN
27
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $11.3M | 0.31% |
1,279,340
| – | – |
|
|
28
Innoviva
INVA
$1.29B
| $5.99M | 0.16% |
331,594
-500,000
| -60% | -$9.04M |
|
29
Theravance Biopharma
TBPH
$699M
| $4.68M | 0.13% |
+359,190
| New | +$4.68M |
|
|
IMGN
30
DELISTED
Immunogen Inc
IMGN
| – | – |
-2,840,816
| Closed | -$25.4M |
|
|
GEVA
31
DELISTED
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
| – | – |
-1,025,476
| Closed | -$100M |
|